Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] HPSP (403870) – Resolution on Convening of Extraordinary General Meeting of Shareholders / 2025-08-07

Posted on August 7, 2025August 2, 2026 By K-STOCK Editor No Comments on [Disclosure] HPSP (403870) – Resolution on Convening of Extraordinary General Meeting of Shareholders / 2025-08-07

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

HPSP has decided to hold an Extraordinary General Meeting of Shareholders on September 18, 2025, to vote on the appointment of Geun-Young Kim as an Inside Director and partial amendments to the Articles of Incorporation.

📊 [Key Disclosure Contents & Summary Metrics]

1. Meeting Schedule and Venue

  • Disclosure Type: Resolution on Convening of Extraordinary General Meeting of Shareholders
  • Meeting Type: Extraordinary General Meeting of Shareholders
  • Date and Time: September 18, 2025, at 09:00 AM
  • Venue: Room 204, Suwon Convention Center, 140 Gwanggyojungang-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do, Korea

2. Proposed Agenda Items

  • Agenda Item 1: Election of Inside Director (Candidate: Geun-Young Kim)
  • Agenda Item 2: Partial Amendments to the Articles of Incorporation

3. Details of Inside Director Candidate

  • Name: Geun-Young Kim
  • Date of Birth: July 1965
  • Term of Office: 1 year and 6 months
  • Appointment Status: Newly Appointed
  • Key Career Background:
    • B.S. in Metallurgical Engineering, Seoul National University
    • M.S. in Materials Science and Engineering, Pohang University of Science and Technology (POSTECH)
    • Former) CEO, International Tech Alliances
    • Former) Managing Director, Dow Chemical Korea Ltd.
    • Former) CEO, Sunghyun Technology Co., Ltd.
    • Current) Advisor, Crescendo Equity Partners

4. Board Resolution Details

  • Board Resolution Date: August 07, 2025
  • Outside Directors Attendance: 2 Present, 1 Absent

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Proposed Agenda Details and Subsequent Disclosure Filings

Through this Board resolution, the schedule and proposed agenda items for the Extraordinary General Meeting of Shareholders have been set. Reviewing the candidate’s detailed profile and the specific reasons for modifying the Articles of Incorporation is essential for understanding changes in corporate governance and strategic direction. Further details can be verified in the “Notice of Convocation of General Meeting of Shareholders” and “Reference Documents” filed prior to the meeting, as well as the “Results of Extraordinary General Meeting of Shareholders” disclosure after the vote.

📢 Disclaimer and Source Information

Source: This content was structured and generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Notice: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial liabilities rest entirely with the individual investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] HPSP (403870) – Setting of Record Date or Closure of Register of Shareholders / 2025-08-07
Next Post: [Disclosure] Wonik IPS (240810) – Consolidated Financial Results (Provisional) / 2025-08-07

Related Posts

[Disclosure] Jeju Semiconductor(080220) – Decision on Issuance of Convertible Bonds (9th Series) / 2026-03-13 Semiconductors
[Disclosure] Hanwha Ocean (042660) – Resumption of Production / 2024-09-10 Disclosures
[Disclosure] Celltrion (068270) – Treasury Share Acquisition Decision / 2025-03-21 Disclosures
[Disclosure] Celltrion (068270) – CHMP Positive Opinion Granted for CT-P43 (Stelara Biosimilar) by EMA / 2024-07-01 Disclosures
[Disclosure] Celltrion (068270) – Decision on Paid-in Capital Increase by Subsidiary (Correction) / 2026-05-11 Disclosures
[Disclosure] ALTEOGEN (196170) – Execution of Exclusive License Agreement (ALT-B4 Technology) / 2024-11-08 Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Aerospace (012450) – Decision on Convening General Meeting of Shareholders / 2026-08-07August 7, 2026
  • [Disclosure] Hanwha Aerospace (012450) – Setting of Record Date for Shareholder Register Closure / 2026-08-07August 7, 2026
  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme